Our news journalists obtained a quote from the research, "Dendritic cell-derived exosomes (Dex) have received much attention as immunotherapeutic anticancer agents since the discovery that they harbor functional MHC-peptide complexes, in addition to various other immune-stimulating components, that together facilitate immune cell-dependent tumor rejection. The therapeutic potential of Dex has been substantiated with their development and clinical testing in the treatment of cancer."
According to the news editors, the research concluded: "This review focuses on mechanisms by which Dex interact with and influence immune cells and describes how they can be engineered to promote their immunogenic capacity as novel and dynamic anticancer agents."
For more information on this research see: Dendritic Cell-Derived Exosomes as Immunotherapies in the Fight against Cancer.
The news correspondents report that additional information may be obtained from
Keywords for this news article include: Antigen-Presenting Cells,
Our reports deliver fact-based news of research and discoveries from around the world. Copyright 2014, NewsRx LLC
Most Popular Stories
- FedEx Adding 50,000 Holiday Jobs
- Plus-Size iPhones Live Up to The Hype
- Cool Features on Today's New iOS 8
- Toxic Algae Threatens Florida Fishing, Tourism
- Family Dollar Spurning Bid From Dollar General
- Kohl's Hiring 67,000 for the Holidays
- Occupy Wall Street Buys Up Student Debt
- Fed Signals It Will Keep Key Rate at Record Low
- Eva Mendes Gives Birth to a Baby Girl
- Stocks Rise Before Fed Statement